Photo via Toronto Star

Abbott agrees to settlement over closure of largest baby formula plant in the US

Read the original at Toronto Star ↗
Cite

Chapman, M. (2026, September 14). Abbott agrees to settlement over closure of largest baby formula plant in the US. Toronto Star. https://www.thestar.com/news/world/united-states/abbott-agrees-to-settlement-over-closure-of-largest-baby-formula-plant-in-the-us/article_0029b5a7-fa9c-5ac7-9a23-c3a9b09882f6.html

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Toronto Star · collected 2026-09-14 · by Michelle Chapman

Quick Summary

Abbott Laboratories has agreed to settle for $385 million regarding the closure of its Sturgis, Michigan baby formula plant in 2022 due to contamination issues. This settlement resolves claims brought by the Justice Department following a federal investigation into the factory, which led to nationwide shortages of powdered infant formula.
Written by AI on 2026-09-14, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

AI analysis

Story summary

Abbott Laboratories, a major baby formula manufacturer, agreed to pay $385 million to settle civil False Claims Act cases with the U.S. Justice Department and several states over bacterial contamination at its largest plant in Sturgis, Michigan. The settlement resolves claims that powdered infant formula made at this facility was contaminated with Cronobacter bacteria during manufacturing, posing a risk to public health. This case followed a 2022 recall of Abbott's products after four infants fell ill from consuming the formula manufactured there. The Justice Department initially sought felony charges but later opted for a civil resolution under pressure from senior leadership. Despite this settlement, Abbott maintains it did not admit liability or fault and emphasizes no unopened distributed product tested positive for bacteria. The plant closure exacerbated existing supply shortages caused by disruptions during the COVID-19 pandemic.

Written for “Abbott Formula Settlement” on 2026-11-20, grounded in this article and the 4 other(s) covering the same event.

How they differ

5 outlets covered “Abbott Formula Settlement”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

Toronto StarThis outlet14 Sep

Abbott Laboratories has agreed to settle for $385 million regarding the closure of its Sturgis, Michigan baby formula plant in 2022 due to contamination issues. This settlement resolves claims brought by the Justice Department following a federal investigation into the factory, which led to nationwide shortages of powdered infant formula.

Abbott agrees to settlement over closure of largest baby formula plant in the US (this article)
CBS News14 Sep

Abbott Laboratories agreed to pay nearly $385 million to settle a civil False Claims Act case with the Justice Department and several states regarding bacterial contamination at its Michigan baby formula plant. The settlement, announced on Monday, resolves allegations that Abbott caused government programs to purchase powdered infant formula made in unsanitary conditions, potentially endangering infants' health…

Abbott Labs to pay nearly $385M in case over bacterial contamination at plant →
ABC News (US)14 Sep

Abbott Laboratories has agreed to a $385 million settlement with the Justice Department over issues related to its Michigan baby formula factory, which closed due to contamination concerns in early 2022. This closure exacerbated existing supply shortages caused by pandemic-related disruptions. The company maintains it did not admit fault or liability and highlights that tests of unopened products found no harmful…

Abbott agrees to settlement over closure of largest baby formula plant in the US →
UPI15 Sep

Abbott Laboratories agreed to pay $385 million to resolve federal allegations related to the contamination at its Sturgis, Michigan infant formula plant in 2022. The settlement addresses claims under the False Claims Act without admitting fault. Four infants fell ill and two died after consuming contaminated formula from the facility, which was closed due to safety violations including roof leaks and malfunctioning…

Abbott to pay $385M over infant formula contamination probe →
The Independent15 Sep

Abbott Laboratories has agreed to pay $385 million to settle legal claims related to a 2022 baby formula shortage caused by a recall at its Sturgis, Michigan plant. The Justice Department initiated a lawsuit amid concerns over bacterial contamination, leading to a nationwide recall of Abbott's major infant formula brands like Similac and exacerbating existing supply chain issues. While the settlement does not admit…

Baby formula maker Abbott Labs agrees to settlement over closure of largest US plant →

Where they agree and split

Framing

How the first headlines put it

Stated as fact5
The headlines (5)

Abbott Labs to pay nearly $385M in case over bacterial contamination at plant CBS News · stated as fact

Abbott agrees to settlement over closure of largest baby formula plant in the US ABC News · stated as fact

Abbott agrees to settlement over closure of largest baby formula plant in the US Toronto Star · stated as fact

Abbott to pay $385M over infant formula contamination probe UPI · stated as fact

Baby formula maker Abbott Labs agrees to settlement over closure of largest US plant The Independent · stated as fact

The full story: what happened, how it changed, and all 5 articles →

Compared with similar articles

This article reads unscored and hedges 50% of its claims. Each row says how that neighbour differs.
ABC News (US)
Leans left Hedges 1 of 9 claims Outlet record 67/100
CBS News
Hedges 4 of 14 claims Outlet record 67/100
The Independent
Centre Hedges 1 of 8 claims Outlet record 59/100
UPI
Hedges 4 of 13 claims Outlet record 56/100

Story

Abbott Formula Settlement
Economy/Business · 5 article(s) covering the same event. Compare every outlet's account →
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
2
sentences that state something as happening or true
Uncertain
50%
1 of 2 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
64/100
Toronto Star's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
5
Economy/Business
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-14 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Toronto Star · 16185 article(s) · 31 correction(s) detected
Running correction rate · 31 correction(s)
2026-11-17
Correction
2026-10-26
Correction
2026-10-24
Correction
2026-10-07
Correction
2026-09-24
Correction

Who wrote this

Michelle Chapman
9 article(s) here · 1 carrying a prediction
In May, Microsoft planned to offer buyouts to about 8,750 people, or 7% of its US workforce, according to two people familiar with the plan who were not authorized to speak about it publicly.
The economy, inflation and how those forces could impact the lives of Americans were front and center over the past week.
The Brightline companies that bet more than $5 billion on developing the nation’s only privately held passenger railroad are reworking their debt in bankruptcy court, but the bright yellow trains will continue running between Miami and Orlando.
Buffett, 96, will assume the role of chairman emeritus immediately, the company announced on Friday.
Buffett, 96, will become chairman emeritus and will take on his new role immediately, the company said Friday.
Abbott Laboratories will pay $385 million to resolve legal claims arising from a contamination inquiry at its baby formula manufacturing plant in Sturgis, Michigan, the nation's largest, which triggered severe supply shortages in 2022.
Drivers seeking to save money by purchasing motor oil to complete their own vehicle oil changes may view the move as another financial strain, while already dealing with elevated grocery bills and widespread concerns over ongoing inflation.
Abbott Laboratories will pay $385 million to resolve claims tied to an investigation of contamination at a baby formula factory in Sturgis, Michigan, the largest in the country, which led to the supply shortages in 2022.
Also by Michelle Chapman
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 9 articles by Michelle Chapman →

Topics

Abbott Laboratories Michigan Sturgis the Justice Department

Subjects

Abbott Laboratories ORG · 1× Michigan GPE · 1× Sturgis GPE · 1× the Justice Department ORG · 1×

Narrative

Problems at the facility prompted a lawsuit by the Justice Department and recall of powdered infant formula at the facility.
framing: mixed · carried by 1 article(s) · first seen 2026-09-14
Abbott Laboratories will pay $385 million to resolve claims tied to an investigation of contamination at a baby formula factory in Sturgis, Michigan, the largest in the country, which led to the supply shortages in 2022.

Claims (2 extracted, 1 hedged)

Abbott Laboratories will pay $385 million to resolve claims tied to an investigation of contamination at a baby formula factory in Sturgis, Michigan, the largest in the country, which led to the supply shortages in 2022. uncertain
which → pay → 2022
Problems at the facility prompted a lawsuit by the Justice Department and recall of powdered infant formula at the facility. asserted
Problems → prompt → facility
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support